BullBD Old Apps Site
Home
Details Chart Today news Share news Top gainer Top Looser Upcoming events
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0 1 2 3 4 5 6 7 8 9 All
Bank Cement Ceramics Sector Corporate Bond Engineering Financial Institutions Food & Allied Fuel & Power IT Sector Insurance Jute Life Insurance Miscellaneous Mutual Funds Paper & Printing Pharmaceuticals & Chemicals Services & Real Estate Tannery Industries Telecommunication Textile Travel & Leisure All
  • Details
  • Chart
  • News

PHARMAID

All Eps Dividend Board Agm Q1 Q2 Q3

PHARMAID 12-Nov-2017

The Board of Directors has recommended 35% cash dividend for the year ended on June 30, 2017. Date of AGM: 28.12.2017, Time: 11:00 AM, Venue: Kendrio Kanchi Kancher Mela Auditorium, 37/A Segun Bagicha, Dhaka-1000. Record date: 04.12.2017. The Company has also reported EPS of Tk. 9.48, NAV per share of Tk. 49.53 and NOCFPS of Tk. 4.09 for the year ended on June 30, 2017 as against Tk. 7.52, Tk. 43.24 and Tk. 6.39 respectively for the same period of the previous year.

PHARMAID 01-Nov-2017

As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 09, 2017 at 3:30 PM to consider, among others, audited financial statements of the Company for the year ended on June 30, 2017.

PHARMAID 08-Oct-2017

The Company has informed that the Board of Directors has been taken a decision for importing one Set of Brand New Machinery with Finishing Line from Europe for a total value of Tk. 2.36 crore (approx) for manufacturing Neutral Glass Ampoules.

PHARMAID 02-May-2017

(Q3 Un-audited): EPS was Tk. 2.27 for January-March 2017 as against Tk. 1.71 for January-March 2016; EPS was Tk. 7.17 for July 2016-March 2017 as against Tk. 5.72 for July'15-March'16. NOCFPS was Tk. (2.90) for July 2016-March 2017 as against Tk. 0.29 for July 2015-March 2016. NAV per share was Tk. 46.62 as of March 31, 2017 and Tk. 42.45 as of June 30, 2016.

PHARMAID 25-Apr-2017

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 30, 2017 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended on March 31, 2017.

PHARMAID 31-Jan-2017

(Q2 Un-audited): EPS was Tk. 2.90 for October-December, 2016 as against Tk. 2.46 for October-December, 2015; EPS was Tk. 4.90 for July-December, 2016 as against Tk. 4.01 for July-December, 2015. NOCFPS was Tk. (1.03) for July-December, 2016 as against Tk. 1.33 for July-December, 2015. NAV per share was Tk. 44.35 as of December 31, 2016 and Tk. 42.45 as of June 30, 2016.

PHARMAID 25-Jan-2017

The Company has further informed that the meeting will now be held on January 30, 2017 at 3:30 PM instead of January 26, 2017 to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended on December 31, 2016.

PHARMAID 24-Jan-2017

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 26, 2017 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended on December 31, 2016.

PHARMAID 29-Dec-2016

National Credit Ratings Limited (NCR) has announced the surveillance rating of the Company as "A-" in the Long Term based on audited financial statements of the Company as on June 30, 2016.

PHARMAID 04-Dec-2016

Trading of the shares of the Company will resume on 05.12.2016 after record date.

Previous Next page